Clinical performance of biological and mechanical prostheses. 1995

G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
Division of Cardiovascular and Thoracic Surgery, University of British Columbia, Vancouver, Canada.

Prosthetic valve replacement remains the most viable alternative for the treatment of severely diseased heart valves. The cumulative experience of mechanical protheses and bioprostheses was evaluated for a 10-year performance comparison: Carpentier-Edwards standard porcine bioprosthesis (CE-S), 1,214 operations; Carpentier-Edwards supraannular porcine bioprosthesis (CE-SAV), 2,489; and mechanical prostheses, 1,364 operations (St. Jude Medical, Carbomedics, Duromedics, and Björk-Shiley Monostrut). The freedom from thromboembolism and hemorrhage at 10 years was 82% for CE-S, 78% for CE-SAV, and 65% for mechanical prostheses (p < 0.05). The relationship existed for major thromboembolism and hemorrhage, 91% (CE-S), 87% (CE-SAV), and 88% (mechanical) (p < 0.05), without clinical relevance. The freedom from structural valve deterioration and valve-related reoperation favored mechanical prostheses (p < 0.05) at 10 years (structural failure: 78% for CE-S, 81% for CE-SAV, and 99% for the mechanical group; reoperation: 74% for CE-S, 76% for CE-SAV, and 88% for mechanical prostheses). The freedom from fatal reoperation was not clinically different: 96% for CE-S, 99% for CE-SAV, and 99% for mechanical prostheses (p < 0.05) at 10 years. The freedom from valve-related mortality was not different (p = not significant) at 10 years: 87% for CE-S; 92% for CE-SAV; and 91% for mechanical. The freedom from permanent impairment or residual morbidity, primarily from thromboembolism, was 95% for CE-S, 92% for CE-SAV, and 95% for mechanical group (p < 0.05) but not clinically relevant.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011475 Prosthesis Failure Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking. Prosthesis Loosening,Prosthesis Durability,Prosthesis Migration,Prosthesis Survival,Durabilities, Prosthesis,Durability, Prosthesis,Failure, Prosthesis,Failures, Prosthesis,Loosening, Prosthesis,Loosenings, Prosthesis,Migration, Prosthesis,Migrations, Prosthesis,Prosthesis Durabilities,Prosthesis Failures,Prosthesis Loosenings,Prosthesis Migrations,Prosthesis Survivals,Survival, Prosthesis,Survivals, Prosthesis
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000206 Actuarial Analysis The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. Analysis, Actuarial,Actuarial Analyses,Analyses, Actuarial
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
January 1984, Kardiologia polska,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
April 2024, JAMA network open,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
November 1995, Circulation,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
January 2018, Nature reviews. Cardiology,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
August 1989, The Annals of thoracic surgery,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
May 1990, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
January 1953, Deutsche zahnarztliche Zeitschrift,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
December 1982, Revista de medicina de la Universidad de Navarra,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
April 2000, The Annals of thoracic surgery,
G J Fradet, and W R Jamieson, and J G Abel, and S V Lichtenstein, and R T Miyagishima, and H Ling, and G F Tyers
January 1986, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
Copied contents to your clipboard!